HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 909.32 Thousand USD | -54.25% |
| 2021 | 1.98 Million USD | 33.22% |
| 2020 | 1.49 Million USD | 17.52% |
| 2019 | 1.26 Million USD | -2.83% |
| 2018 | 1.3 Million USD | 10.68% |
| 2017 | 1.18 Million USD | -21.87% |
| 2016 | 1.51 Million USD | -31.36% |
| 2015 | 2.2 Million USD | 49.22% |
| 2014 | 1.47 Million USD | 98.24% |
| 2013 | 744.17 Thousand USD | 504.43% |
| 2012 | 123.11 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 654.91 Thousand USD | -27.98% |
| 2023 Q2 | - USD | -100.0% |
| 2022 Q1 | 2.02 Million USD | 1.75% |
| 2022 FY | 909.32 Thousand USD | -54.25% |
| 2022 Q2 | 1.95 Million USD | -3.29% |
| 2022 Q4 | 909.32 Thousand USD | -46.2% |
| 2022 Q3 | 1.69 Million USD | -13.58% |
| 2021 Q2 | 2.31 Million USD | 44.62% |
| 2021 Q1 | 1.6 Million USD | 7.42% |
| 2021 FY | 1.98 Million USD | 33.22% |
| 2021 Q3 | 2.34 Million USD | 0.98% |
| 2021 Q4 | 1.98 Million USD | -15.08% |
| 2020 Q4 | 1.49 Million USD | -3.02% |
| 2020 Q2 | 1.38 Million USD | -15.22% |
| 2020 Q1 | 1.63 Million USD | 29.0% |
| 2020 FY | 1.49 Million USD | 17.52% |
| 2020 Q3 | 1.53 Million USD | 10.8% |
| 2019 Q1 | 1.17 Million USD | -9.76% |
| 2019 Q4 | 1.26 Million USD | 6.54% |
| 2019 Q2 | 1.16 Million USD | -1.56% |
| 2019 FY | 1.26 Million USD | -2.83% |
| 2019 Q3 | 1.19 Million USD | 2.68% |
| 2018 Q1 | 1.04 Million USD | -11.73% |
| 2018 FY | 1.3 Million USD | 10.68% |
| 2018 Q3 | 1.12 Million USD | 12.62% |
| 2018 Q4 | 1.3 Million USD | 15.72% |
| 2018 Q2 | 1 Million USD | -3.79% |
| 2017 Q1 | 1.25 Million USD | -16.92% |
| 2017 FY | 1.18 Million USD | -21.87% |
| 2017 Q4 | 1.18 Million USD | -5.62% |
| 2017 Q3 | 1.25 Million USD | -4.78% |
| 2017 Q2 | 1.31 Million USD | 4.63% |
| 2016 Q1 | 2.36 Million USD | 7.48% |
| 2016 Q2 | 2.21 Million USD | -6.46% |
| 2016 Q3 | 1.86 Million USD | -15.61% |
| 2016 Q4 | 1.51 Million USD | -19.09% |
| 2016 FY | 1.51 Million USD | -31.36% |
| 2015 FY | 2.2 Million USD | 49.22% |
| 2015 Q1 | 2.09 Million USD | 42.05% |
| 2015 Q4 | 2.2 Million USD | -2.86% |
| 2015 Q3 | 2.26 Million USD | -6.05% |
| 2015 Q2 | 2.41 Million USD | 15.11% |
| 2014 Q4 | 1.47 Million USD | 14.21% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q2 | 934.26 Thousand USD | 0.0% |
| 2014 Q3 | 1.29 Million USD | 38.25% |
| 2014 FY | 1.47 Million USD | 98.24% |
| 2013 Q4 | 744.17 Thousand USD | 0.0% |
| 2013 FY | 744.17 Thousand USD | 504.43% |
| 2012 FY | 123.11 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -139.928% |
| Arrayit Corporation | 464.19 Thousand USD | -95.895% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -20.123% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 38226.96% |
| DermTech, Inc. | 1 Million USD | 9.429% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 72.437% |
| iMD Companies, Inc. | 38.31 Thousand USD | -2273.233% |
| IDenta Corp. | 442.28 Thousand USD | -105.6% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 25.89% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -457.408% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -15.986% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 242587.467% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -93.98% |
| PharmChem, Inc. | 391.93 Thousand USD | -132.009% |
| Proteome Sciences plc | 1.06 Million USD | 14.657% |
| Response Genetics, Inc | 133 Thousand USD | -583.705% |
| Rennova Health, Inc. | 242.64 Thousand USD | -274.757% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -1130.534% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -850.971% |
| Todos Medical Ltd. | 1.02 Million USD | 10.937% |